|
⚲
|
| Keyboard |
| Peterson Katharine
✚
|
|
|---|---|
| CIK # | 0002022214 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002022214] | |
| 4 | [0002022214] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Peterson Katharine | |
| Acrivon Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Acrivon Therapeutics Inc ACRV
Stock Option (Right to Buy) · derivative
|
2026-03-01 | Grant | 31,900 | $0.00 | |
|
Acrivon Therapeutics Inc ACRV
Common Stock
|
2026-02-14 | Tax withheld | 116 | $1.63 | 189 |
|
Acrivon Therapeutics Inc ACRV
Common Stock
|
2025-11-14 | Tax withheld | 99 | $2.24 | 222 |
|
Acrivon Therapeutics Inc ACRV
Common Stock
|
2025-08-14 | Tax withheld | 99 | $1.39 | 138 |
|
Acrivon Therapeutics Inc ACRV
Common Stock
|
2025-05-14 | Tax withheld | 99 | $1.14 | 113 |
|
Acrivon Therapeutics Inc ACRV
Stock Option (Right to Buy) · derivative
|
2025-03-01 | Grant | 31,900 | $0.00 | |
|
Acrivon Therapeutics Inc ACRV
Common Stock
|
2025-02-14 | Tax withheld | 116 | $5.42 | 629 |
|
Acrivon Therapeutics Inc ACRV
Common Stock
|
2024-11-14 | Tax withheld | 99 | $7.92 | 784 |
|
Acrivon Therapeutics Inc ACRV
Common Stock
|
2024-08-14 | Tax withheld | 99 | $7.02 | 695 |
|
Acrivon Therapeutics Inc ACRV
Common Stock
|
2024-05-14 | Tax withheld | 99 | $8.36 | 828 |